Abstract
A novel and highly sensitive flow injection chemiluminescence (FI-CL) method has been developed for the assay of isoxicam. The method is based on the luminescence of the diperiodatoargentate(III)-fluorescein-isoxicam system, where fluorescein is used as an energy-transfer reagent in alkaline medium. The emission intensity is greatly enhanced by the presence of cetyltrimethylammonium bromide (CTAB). Optimum conditions and possible mechanisms have been investigated. The relative CL intensity is linear with the isoxicam concentration in the range of 3.0×10−10–1.0×10−6g/ml with a detection limit of 7.0×10−11g/ml (3σ). The relative standard deviation (RSD) is 1.7% at 1.0×10−8g/ml of isoxicam (n=11). The present CL procedure was successfully applied to the determination of isoxicam in pharmaceutical formulations and biological fluids.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
